Citations (78)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Cornélie Fanton D’Andon, Patricia Correia, Josselin Rigaill, Benjamin Kably, Sophie Perinel-Ragey & Manon Launay. (2022) Ceftazidime dosing in obese patients: is it time for more?. Expert Opinion on Drug Metabolism & Toxicology 18:4, pages 277-284.
Read now
Read now
Navaneeth Narayanan, Christopher D Adams, David W Kubiak, Serena Cheng, Robyn Stoianovici, Leonid Kagan & Luigi Brunetti. (2019) Evaluation of treatment options for methicillin-resistant Staphylococcus aureus infections in the obese patient. Infection and Drug Resistance 12, pages 877-891.
Read now
Read now
Dion R Brocks, Mohamed Ben-Eltriki, Raniah Q Gabr & Raj S Padwal. (2012) The effects of gastric bypass surgery on drug absorption and pharmacokinetics. Expert Opinion on Drug Metabolism & Toxicology 8:12, pages 1505-1519.
Read now
Read now
Articles from other publishers (75)
Victoria Speed, Julia Czuprynska, Jignesh P. Patel & Roopen Arya. (2023) Use of direct oral anticoagulants for venous thromboembolism treatment at extremes of body weight, renal and liver function: an illustrated review. Research and Practice in Thrombosis and Haemostasis 7:8, pages 102240.
Crossref
Crossref
Marco Cefalì, Isabel Scala, Giuliana Pavone, Daniel Helbling, Saskia Hussung, Ralph Fritsch, Cäcilia Reiner, Soleen Stocker, Dieter Koeberle, Marc Kissling, Vito Chianca, Filippo Del Grande, Sara De Dosso & Stefania Rizzo. (2023) Is Computed-Tomography-Based Body Composition a Reliable Predictor of Chemotherapy-Related Toxicity in Pancreatic Cancer Patients?. Cancers 15:17, pages 4398.
Crossref
Crossref
Min Hu, Yiduo Ding, Haizhou Zhang, Wei Guo, Yun Li, Zhengming Jin, Changju Qu & Fan Xia. (2023) Body mass index-associated responses to an ABVD-like regimen in newly-diagnosed patients with Hodgkin lymphoma. Frontiers in Pharmacology 14.
Crossref
Crossref
Lauren Wright, Darrell T. Childress, Matthew L. Brown, Wes Wilkerson, Ricardo Maldonado & Spencer H. Durham. (2022) Which “weigh” to Go? Alternative Vancomycin Dosing Strategies in Obese Patients. Journal of Pharmacy Practice 36:4, pages 870-874.
Crossref
Crossref
Yazed S Alsowaida, Ahmad Alamer, Abrar K Thabit, Abdulaziz S Almulhim, Muneerah M Aleissa, Alireza Kalbasi, Khaled Eljaaly, Thamer A Almangour & Brian L Erstad. (2023) Echinocandin exposures in obese patients: A scoping review and clinical perspectives. American Journal of Health-System Pharmacy 80:8, pages 503-517.
Crossref
Crossref
Soedarsono Soedarsono, Rannissa Puspita Jayanti, Ni Made Mertaniasih, Tutik Kusmiati, Ariani Permatasari, Dwi Wahyu Indrawanto, Anita Nur Charisma, Elvina Elizabeth Lius, Rika Yuliwulandari, Pham Quang Hoa, Nguyen Ky Phat, Vo Thuy Anh Thu, Nguyen Ky Anh, Sangzin Ahn, Nguyen Phuoc Long, Yong-Soon Cho & Jae-Gook Shin. (2023) Development of population pharmacokinetics model and Bayesian estimation of rifampicin exposure in Indonesian patients with tuberculosis. Tuberculosis 139, pages 102325.
Crossref
Crossref
Cyril Leven, Pauline Ménard, Isabelle Gouin-Thibault, Alice Ballerie, Karine Lacut, Edouard Ollier & Jérémie Théreaux. (2023) Transferability of Published Population Pharmacokinetic Models for Apixaban and Rivaroxaban to Subjects with Obesity Treated for Venous Thromboembolism: A Systematic Review and External Evaluations. Pharmaceutics 15:2, pages 665.
Crossref
Crossref
Meg J Spriggs, Bruna Giribaldi, Taylor Lyons, Fernando E Rosas, Laura S Kärtner, Tobias Buchborn, Hannah M Douglass, Leor Roseman, Christopher Timmermann, David Erritzoe, David J Nutt & Robin L Carhart-Harris. (2022) Body mass index (BMI) does not predict responses to psilocybin. Journal of Psychopharmacology 37:1, pages 107-116.
Crossref
Crossref
Ezekwesiri Michael Nwanosike, Wendy Sunter, Hamid A. Merchant, Barbara R. Conway, Muhammad Ayub Ansari & Syed Shahzad Hasan. (2022) Challenges and Possible Solutions to Direct-Acting Oral Anticoagulants (DOACs) Dosing in Patients with Extreme Bodyweight and Renal Impairment. American Journal of Cardiovascular Drugs 23:1, pages 9-17.
Crossref
Crossref
Zekiye Soykan Sert & Mete Bertizlioğlu. (2022) Effect of obesity on the time to a successful medical abortion with misoprostol in first-trimester missed abortion. Archives of Gynecology and Obstetrics.
Crossref
Crossref
David J. Greenblatt, Christopher D. Bruno, Jerold S. Harmatz, Qingchen Zhang & Christina R. Chow. (2022) Drug Disposition in Subjects With Obesity: The Research Work of Darrell R. Abernethy. The Journal of Clinical Pharmacology 62:11, pages 1350-1363.
Crossref
Crossref
Anning Xiong, Wei Nie, Lei Cheng, Hua Zhong, Tianqing Chu, Runbo Zhong, Jun Lu, Shuyuan Wang, Jianlin Xu, Yinchen Shen, Feng Pan, Baohui Han & Xueyan Zhang. (2022) Association Between Obesity and Poor Prognosis in Patients Receiving Anlotinib for Advanced Non-Small Cell Lung Cancer. Frontiers in Pharmacology 13.
Crossref
Crossref
Merel van Nuland, Tessa F. Ververs & Marnix G. E. H. Lam. (2022) Dosing Therapeutic Radiopharmaceuticals in Obese Patients. International Journal of Molecular Sciences 23:2, pages 818.
Crossref
Crossref
Dhafer A.F. Al-Koofee, Ali M. Omara, Ali B. Abulrazzaq & Ruqayah Zaid. (2022) The risk factor for instability metabolic health and severity. Materials Today: Proceedings 60, pages 1606-1610.
Crossref
Crossref
Christopher D. Bruno, Ahmed Elmokadem, Conrad Housand, Eric Burroughs Jordie, Christina R. Chow, Thomas P. Laughren & David J. Greenblatt. (2021) Impact of Obesity on Brexpiprazole Pharmacokinetics: Proposal for Improved Initiation of Treatment. The Journal of Clinical Pharmacology 62:1, pages 55-65.
Crossref
Crossref
Kenneth H. Wills, Stephen J. Behan, Michael J. Nance, Jessica L. Dawson, Thomas M. Polasek, Ashley M. Hopkins, Madelé van Dyk & Andrew Rowland. (2021) Combining Therapeutic Drug Monitoring and Pharmacokinetic Modelling Deconvolutes Physiological and Environmental Sources of Variability in Clozapine Exposure. Pharmaceutics 14:1, pages 47.
Crossref
Crossref
N. Steenackers, L. Wauters, B. Van der Schueren, P. Augustijns, G. Falony, M. Koziolek, M. Lannoo, A. Mertens, A. Meulemans, J. Raes, R. Vangoitsenhoven, S. Vieira-Silva, W. Weitschies, C. Matthys & T. Vanuytsel. (2021) Effect of obesity on gastrointestinal transit, pressure and pH using a wireless motility capsule. European Journal of Pharmaceutics and Biopharmaceutics 167, pages 1-8.
Crossref
Crossref
Michelle C. Lamarche, Eman Alrajhi & Philip S. Wells. (2021) Direct oral anticoagulant use in special populations. Current Opinion in Pulmonary Medicine 27:5, pages 311-318.
Crossref
Crossref
Ana Luiza P.P.d.P. Soares, Maiara C. Montanha, Conrado d.S. Alcantara, Sandra R.B. Silva, Cristina M. Kuroda, Sérgio S. Yamada, Antônio E. Nicacio, Liane Maldaner, Jesui V. Visentainer, Caroline F. Simões, João Carlos Locatelli, Wendell A. Lopes, Josmar Mazucheli, Andrea Diniz, Paulo J.P.A. Paixão & Elza Kimura. (2021) Pharmacokinetics of amoxicillin in obese and nonobese subjects. British Journal of Clinical Pharmacology 87:8, pages 3227-3233.
Crossref
Crossref
Christopher D. Bruno, Jerold S. Harmatz, Su X. Duan, Qingchen Zhang, Christina R. Chow & David J. Greenblatt. (2021) Effect of lipophilicity on drug distribution and elimination: Influence of obesity. British Journal of Clinical Pharmacology 87:8, pages 3197-3205.
Crossref
Crossref
N. Silvestris, A. Argentiero, A. Natalicchio, S. D'Oronzo, G.D. Beretta, S. Acquati, V. Adinolfi, P. Di Bartolo, R. Danesi, A. Faggiano, P. Ferrari, M. Gallo, S. Gori, L. Morviducci, A. Russo, E. Tuveri, M.C. Zatelli, M. Montagnani & F. Giorgino. (2021) Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper. ESMO Open 6:3, pages 100153.
Crossref
Crossref
Xin Song, Changzhou Cai, Qi Jin, Xueyang Chen & Chaohui Yu. (2021)
The efficacy of
Helicobacter pylori
eradication in diabetics and its effect on glycemic control: A systematic review and meta‐analysis
. Helicobacter 26:2.
Crossref
Crossref
Evan M. White & James C. Coons. (2021) Direct Oral Anticoagulant Use in Special Populations: Elderly, Obesity, and Renal Failure. Current Cardiology Reports 23:4.
Crossref
Crossref
Brian L. Erstad & Jeffrey F. Barletta. (2021) Drug dosing in the critically ill obese patient: a focus on medications for hemodynamic support and prophylaxis. Critical Care 25:1.
Crossref
Crossref
Arunkumar Krishnan, James P Hamilton, Saleh A Alqahtani & Tinsay A Woreta. (2021) COVID-19: An overview and a clinical update. World Journal of Clinical Cases 9:1, pages 8-23.
Crossref
Crossref
O.M. Drapkina, O.T. Kim & V.A. Dadaeva. (2021) Obese patient safety: is it possible to predict the risks at all stages of medical care?. Profilakticheskaya meditsina 24:3, pages 87.
Crossref
Crossref
Roberta Bottino, Andreina Carbone, Biagio Liccardo, Paolo Golino, Gerardo Nigro & Vincenzo Russo. 2021. Direct Oral Anticoagulants. Direct Oral Anticoagulants
149
178
.
See Kwok, Safwaan Adam, Jan Hoong Ho, Zohaib Iqbal, Peter Turkington, Salman Razvi, Carel W. Le Roux, Handrean Soran & Akheel A. Syed. (2020)
Obesity: A critical risk factor in the
COVID
‐19 pandemic
. Clinical Obesity 10:6.
Crossref
Crossref
Sarah Seiberth, Dominik Bauer, Ulf Schönermarck, Hanna Mannell, Christian Stief, Joerg Hasford & Dorothea Strobach. (2020) Correct use of non-indexed eGFR for drug dosing and renal drug-related problems at hospital admission. European Journal of Clinical Pharmacology 76:12, pages 1683-1693.
Crossref
Crossref
Jamielynn Sebaaly & Denise Kelley. (2020) Direct Oral Anticoagulants in Obesity: An Updated Literature Review. Annals of Pharmacotherapy 54:11, pages 1144-1158.
Crossref
Crossref
Stefan Potente, Frank Ramsthaler, Mattias Kettner, Patrick Sauer & Peter Schmidt. (2020) Relative blood loss in forensic medicine—do we need a change in doctrine?. International Journal of Legal Medicine 134:3, pages 1123-1131.
Crossref
Crossref
Kenneth T. Moore. 2020. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
723
747
.
Katherine H. Ross, Keerthi Gogineni, Preeti D. Subhedar, Jolinta Y. Lin & Lauren E. McCullough. (2019) Obesity and cancer treatment efficacy: Existing challenges and opportunities. Cancer 125:10, pages 1588-1592.
Crossref
Crossref
B. Goubaux. (2019) Anestesia del paciente adulto obeso. EMC - Anestesia-Reanimación 45:1, pages 1-12.
Crossref
Crossref
B. Goubaux. (2019) Gestione anestetica del paziente adulto obeso. EMC - Anestesia-Rianimazione 24:1, pages 1-11.
Crossref
Crossref
Kenneth T. Moore. 2019. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
1
25
.
Jamie Sebaaly & Kelly Covert. (2018) Enoxaparin Dosing at Extremes of Weight: Literature Review and Dosing Recommendations. Annals of Pharmacotherapy 52:9, pages 898-909.
Crossref
Crossref
Frank Z. Stanczyk, Anne E. Burke, Kurt M. Hong & David F. Archer. (2018) Morbid obesity: potential effects of hormonal contraception. Contraception 98:3, pages 174-180.
Crossref
Crossref
David J. GreenblattJerold S. HarmatzChristina R. Chow. (2018) Vortioxetine Disposition in Obesity. Journal of Clinical Psychopharmacology 38:3, pages 172-179.
Crossref
Crossref
Nuggehally R. Srinivas. (2018) Influence of Morbid Obesity on the Clinical Pharmacokinetics of Various Anti-Infective Drugs: Reappraisal Using Recent Case Studies—Issues, Dosing Implications, and Considerations. American Journal of Therapeutics 25:2, pages e224-e246.
Crossref
Crossref
Sarah Maximos, Michel Chamoun, Sophie Gravel, Jacques Turgeon & Veronique Michaud. (2017) Tissue Specific Modulation of cyp2c and cyp3a mRNA Levels and Activities by Diet-Induced Obesity in Mice: The Impact of Type 2 Diabetes on Drug Metabolizing Enzymes in Liver and Extra-Hepatic Tissues. Pharmaceutics 9:4, pages 40.
Crossref
Crossref
Matthew L. Brown, Amber M. Hutchison, Aaron M. McAtee, Philippe R. Gaillard & Darrell T. Childress. (2017) Allometric versus consensus guideline dosing in achieving target vancomycin trough concentrations. American Journal of Health-System Pharmacy 74:14, pages 1067-1075.
Crossref
Crossref
Veronika Tomankova, Pavel Anzenbacher & Eva Anzenbacherova. (2017) Effects of obesity on liver cytochromes P450 in various animal models. Biomedical Papers 161:2, pages 144-151.
Crossref
Crossref
Steven L. ShaferDennis M. Fisher. (2017) Remifentanil Dosing at Extremes of Body Weight. Anesthesiology 126:6, pages 993-994.
Crossref
Crossref
Xavier Cahu, Martin Carré, Christian Recher, Arnaud Pigneux, Mathilde Hunault-Berger, Norbert Vey, Patrice Chevallier, Jacques Delaunay, Emmanuel Gyan, Bruno Lioure, Caroline Bonmati, Chantal Himberlin, Yosr Hicheri, Gaelle Guillerm, Bouscary Didier, Fabrice Larosa, Mario Ojeda-Uribe, Marc Bernard, Marie C. Bene, Norbert Ifrah & Jean-Yves Cahn. (2017) Impact of body-surface area on patients’ outcome in younger adults with acute myeloid leukemia. European Journal of Haematology 98:5, pages 443-449.
Crossref
Crossref
Bjørg Sjøblom, Jūratė Šaltytė Benth, Bjørn H. Grønberg, Vickie E. Baracos, Michael B. Sawyer, Øystein Fløtten, Marianne J. Hjermstad, Nina Aass & Marit Jordhøy. (2017) Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non–Small-Cell Lung Cancer. Clinical Lung Cancer 18:2, pages e129-e136.
Crossref
Crossref
Vincent Madelain, Minh P. Le, Karen Champenois, Charlotte Charpentier, Roland Landman, Veronique Joly, Patrick Yeni, Diane Descamps, Yazdan Yazdanpanah & Gilles Peytavin. (2017) Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case–control study. Journal of Antimicrobial Chemotherapy, pages dkw527.
Crossref
Crossref
Sara Elizabeth Boyd, Esmita Charani, Tracy Lyons, Gary Frost & Alison Helen Holmes. (2016) Information provision for antibacterial dosing in the obese patient: a sizeable absence?. Journal of Antimicrobial Chemotherapy 71:12, pages 3588-3592.
Crossref
Crossref
Öznur Uludağ & Mediha Türktan. (2016) Obezite Hastalarında Anestezi Yönetimi. Arşiv Kaynak Tarama Dergisi 25:22109, pages 406-419.
Crossref
Crossref
Melissa R Hunter, Roy T Sabo, John M McCarty & Ashley M Newland. (2014) Effectiveness and toxicity of high-dose cyclophosphamide in obese versus non-obese patients receiving allogeneic hematopoietic stem cell transplant. Journal of Oncology Pharmacy Practice 22:1, pages 54-59.
Crossref
Crossref
Jamie H. Zao, Tal Schechter, Wenchao Jessica Liu, Sandra Gerges, Adam Gassas, R. Maarten Egeler, Eyal Grunebaum & L. Lee Dupuis. (2015) Performance of Busulfan Dosing Guidelines for Pediatric Hematopoietic Stem Cell Transplant Conditioning. Biology of Blood and Marrow Transplantation 21:8, pages 1471-1478.
Crossref
Crossref
John H. P. Friesen. (2015) Lean Body Weight Is Not a Weight Scalar for Estimating Drug Doses in Morbid Obesity. Obesity Surgery 25:8, pages 1496-1497.
Crossref
Crossref
H. Karl Greenblatt & David J. Greenblatt. (2015) Altered Drug Disposition Following Bariatric Surgery: A Research Challenge. Clinical Pharmacokinetics 54:6, pages 573-579.
Crossref
Crossref
Mary Beth Flynn MakicCarol RauenKimmith JonesAnna C. Fisk. (2015) Continuing to Challenge Practice to Be Evidence Based. Critical Care Nurse 35:2, pages 39-50.
Crossref
Crossref
Danny Tsai, Janattul-Ain Jamal, Joshua S. Davis, Jeffrey Lipman & Jason A. Roberts. (2014) Interethnic Differences in Pharmacokinetics of Antibacterials. Clinical Pharmacokinetics 54:3, pages 243-260.
Crossref
Crossref
James Conor Kinahan, Aoife NiChorcorain, Sean Cunningham, Aideen Freyne, Colm Cooney, Siobhan Barry & Brendan D Kelly. (2015) Risk factors for polyuria in a cross-section of community psychiatric lithium-treated patients. Bipolar Disorders 17:1, pages 50-62.
Crossref
Crossref
Manjunath P. Pai & Joseph S. BertinoJr.Jr.. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
631
707
.
Gillian Bartlett, Vaso Rahimzadeh, Cristina Longo, Lori A Orlando, Martin Dawes, Jean Lachaine, Murielle Bochud, Fred Paccaud, Howard Bergman, Laura Crimi & Amalia M Issa. (2014) The future of genomic testing in primary care: the changing face of personalized medicine. Personalized Medicine 11:5, pages 477-486.
Crossref
Crossref
Olaf H. Drummer. (2014) Alcohol: Pharmacology and Disposition. Academic Forensic Pathology 4:2, pages 128-137.
Crossref
Crossref
G Sandhu, S Mapp, C Carrington & S Hennig. (2014) To Cap or Not to Cap: Chemotherapy Dosing in Obese Adult Hematology Patients. Clinical Pharmacology & Therapeutics 95:4, pages 356-358.
Crossref
Crossref
Maribel Reyes, Matthias Hoch, Patrick Brossard & Jasper Dingemanse. (2014) Effects of Ethnicity and Sex on the Pharmacokinetics and Pharmacodynamics of the Selective Sphingosine-1-Phosphate Receptor 1 Modulator Ponesimod: A Clinical Study in Japanese and Caucasian Subjects. Pharmacology 94:5-6, pages 223-229.
Crossref
Crossref
Manjunath P. Pai. (2014) Serum and urine pharmacokinetics of tigecycline in obese class III and normal weight adults. Journal of Antimicrobial Chemotherapy 69:1, pages 190-199.
Crossref
Crossref
Marco SiccardiRajith Kumar Reddy Rajoli, Paul Curley, Adeniyi Olagunju, Darren Moss & Andrew Owen. (2013) Physiologically based pharmacokinetic models for the optimization of antiretroviral therapy: recent progress and future perspective. Future Virology 8:9, pages 871-890.
Crossref
Crossref
R. Huttunen, M. Karppelin & J. Syrjänen. (2013) Obesity and nosocomial infections. Journal of Hospital Infection 85:1, pages 8-16.
Crossref
Crossref
Katie M Muzevich & Kimberly B Lee. (2013)
Subtherapeutic Linezolid Concentrations in a Patient with Morbid Obesity and Methicillin-Resistant
Staphylococcus aureus
Pneumonia: Case Report and Review of the Literature
. Annals of Pharmacotherapy 47:6, pages e25-e25.
Crossref
Crossref
Sung-Joon Cho, In-Soo Yoon & Dae-Duk Kim. (2013) Obesity-related physiological changes and their pharmacokinetic consequences. Journal of Pharmaceutical Investigation 43:3, pages 161-169.
Crossref
Crossref
John H. P. Friesen. (2012) Lean-scaled weight: a proposed weight scalar to calculate drug doses for obese patients. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 60:2, pages 214-215.
Crossref
Crossref
Lina Badimon, Rodrigo Hernández Vera, Teresa Padró & Gemma Vilahur. (2017) Antithrombotic therapy in obesity. Thrombosis and Haemostasis 110:10, pages 681-688.
Crossref
Crossref
Brett Janson & Karin Thursky. (2012) Dosing of antibiotics in obesity. Current Opinion in Infectious Diseases 25:6, pages 634-649.
Crossref
Crossref
Manjunath P. Pai. (2012) Drug Dosing Based on Weight and Body Surface Area: Mathematical Assumptions and Limitations in Obese Adults. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32:9, pages 856-868.
Crossref
Crossref
E.S. Morgan, E. Wilson, T. Watkins, F. Gao & B.J. Hunt. (2012) Maternal obesity and venous thromboembolism. International Journal of Obstetric Anesthesia 21:3, pages 253-263.
Crossref
Crossref
Charlotte I.S. Barker, Joseph F. Standing, Mark A. Turner, James C. McElnay & Mike Sharland. (2012) Antibiotic dosing in children in Europe. Current Opinion in Infectious Diseases 25:3, pages 235-242.
Crossref
Crossref
Margreke J.E. Brill, Jeroen Diepstraten, Anne van Rongen, Simone van Kralingen, John N. van den Anker & Catherijne A.J. Knibbe. (2012) Impact of Obesity on Drug Metabolism and Elimination in Adults and Children. Clinical Pharmacokinetics 51:5, pages 277-304.
Crossref
Crossref
Eun Jung Park, Manjunath P Pai, Ting Dong, Jialu Zhang, Chia-Wen Ko, John Lawrence, Victor Crentsil, Lei Zhang & Nancy N Xu. (2012) The Influence of Body Size Descriptors on the Estimation of Kidney Function in Normal Weight, Overweight, Obese, and Morbidly Obese Adults. Annals of Pharmacotherapy 46:3, pages 317-328.
Crossref
Crossref
J.P. PATEL, B. GREEN, R.K. PATEL, J.G. DAVIES & R. ARYA. (2012) Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non‐valvular atrial fibrillation from the RE‐LY trial: a rebuttal. Journal of Thrombosis and Haemostasis 10:3, pages 500-502.
Crossref
Crossref